Abbvie (ABBV) Reiterated at Overweight by Cantor Fitzgerald after Analyst Call
June 23, 2026 7:22 AM
Cantor Fitzgerald analyst Carter Gould reiterated an Overweight rating and $240.00 price target on Abbvie (NYSE: ABBV).The analyst commented, "Following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
